OBGYN, maternal-fetal medicine specialist and informed choice advocate Dr. Emiliano Chavira breaks down the methods, outcomes, conclusions, flaws and practical applications of the 2018 “ARRIVE” trial and the resulting push to induce routinely at 39 weeks.

Learn more about your ad choices. Visit megaphone.fm/adchoices